Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geraint Davies

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|February 15, 2012
Pharmacokinetics of rifampin in Peruvian tuberculosis patients with and without comorbid diabetes or HIVAna Requena-Méndez, Geraint Davies, Alison Ardrey, et al.
Thorax|November 3, 2019
Delivery of long-term-injectable agents for TB by lay carers: pragmatic randomised trialDanielle B Cohen, Kuzani Mbendera, Hendramoorthy Maheswaran, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2011
Sequential population pharmacokinetic modeling of lopinavir and ritonavir in healthy volunteers and assessment of different dosing strategiesLaura Dickinson, Marta Boffito, David Back, et al.
Plos One|January 22, 2021
The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigsFaye Lanni, Neil Burton, Debbie Harris, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2018
Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazidAna Requena-Méndez, Geraint Davies, David Waterhouse, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid CultureRobin J Svensson, Wilber Sabiiti, Gibson S Kibiki, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patientsAna Requena-Méndez, Geraint Davies, David Waterhouse, et al.
Nature Communications|June 10, 2026
Pharmacokinetics, bactericidal activity and toxicity of short oral regimens for rifampicin-resistant tuberculosis treatmentBern-Thomas Nyang'wa, Ilaria Motta, Ronelle Moodliar, et al.
Brain Sciences|September 28, 2021
Developing a Digital Solution for Remote Assessment in Multiple Sclerosis: From Concept to Software as a Medical DeviceAnneke van der Walt, Helmut Butzkueven, Robert K Shin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 24, 2007
A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicinRuben C Hartkoorn, Saye Khoo, David J Back, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|February 15, 2012
Pharmacokinetics of rifampin in Peruvian tuberculosis patients with and without comorbid diabetes or HIVAna Requena-Méndez, Geraint Davies, Alison Ardrey, et al.
Thorax|November 3, 2019
Delivery of long-term-injectable agents for TB by lay carers: pragmatic randomised trialDanielle B Cohen, Kuzani Mbendera, Hendramoorthy Maheswaran, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2011
Sequential population pharmacokinetic modeling of lopinavir and ritonavir in healthy volunteers and assessment of different dosing strategiesLaura Dickinson, Marta Boffito, David Back, et al.
Plos One|January 22, 2021
The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigsFaye Lanni, Neil Burton, Debbie Harris, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2018
Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazidAna Requena-Méndez, Geraint Davies, David Waterhouse, et al.
Antimicrobial Agents and Chemotherapy|July 31, 2019
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid CultureRobin J Svensson, Wilber Sabiiti, Gibson S Kibiki, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patientsAna Requena-Méndez, Geraint Davies, David Waterhouse, et al.
Nature Communications|June 10, 2026
Pharmacokinetics, bactericidal activity and toxicity of short oral regimens for rifampicin-resistant tuberculosis treatmentBern-Thomas Nyang'wa, Ilaria Motta, Ronelle Moodliar, et al.
Brain Sciences|September 28, 2021
Developing a Digital Solution for Remote Assessment in Multiple Sclerosis: From Concept to Software as a Medical DeviceAnneke van der Walt, Helmut Butzkueven, Robert K Shin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 24, 2007
A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicinRuben C Hartkoorn, Saye Khoo, David J Back, et al.
Pageof 4